What antidepressant is suitable for a person with excessive alcohol use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antidepressant Selection for Patients with Excessive Alcohol Use

For patients with excessive alcohol consumption, SSRIs like sertraline are the most appropriate antidepressant choice due to their favorable safety profile, potential to reduce alcohol consumption, and lower risk of adverse interactions compared to other antidepressant classes. 1

First-Line Recommendation: SSRIs

Why SSRIs are Preferred:

  • Moderate-quality evidence shows SSRIs can increase the number of alcohol-abstinent days and reduce drinks per drinking day 1
  • SSRIs have minimal risk of developing adverse effects in people with co-occurring depression and alcohol dependence 1
  • They may reduce alcohol consumption by decreasing desire, craving, and liking for alcohol 2

Specific SSRI Recommendations:

  • Sertraline: First choice due to extensive study in alcohol-dependent populations 1
    • Can be taken with or without food
    • Starting dose: 50mg daily, titrated as needed
    • Monitor for potential side effects including anxiety, insomnia, or sexual dysfunction

Medications to Avoid

Tricyclic Antidepressants:

  • Higher risk of cardiotoxic, hypotensive, and anticholinergic effects 3
  • Potentially dangerous interactions with alcohol

Bupropion:

  • Contraindicated due to significantly increased seizure risk in alcohol users 4
  • Alcohol lowers seizure threshold, compounding bupropion's known seizure risk

Benzodiazepines:

  • Regular use can lead to tolerance, addiction, depression, and cognitive impairment 3
  • Paradoxical agitation occurs in about 10% of patients 3
  • High risk of abuse potential in patients with alcohol use disorder 3

Important Monitoring Considerations

  1. Assess for alcohol withdrawal symptoms:

    • Use the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale 3
    • Score >8 indicates moderate withdrawal; ≥15 indicates severe withdrawal
  2. Watch for pathological intoxication:

    • Some patients on SSRIs may experience unexpected disinhibition when consuming alcohol 5
    • Memory impairment is common in these cases
    • Warn patients about this potential interaction
  3. Monitor hepatic function:

    • Alcohol use disorder often affects liver function
    • Adjust medication dosing accordingly

Adjunctive Treatments

For Alcohol Use Disorder:

  • Naltrexone (50mg daily) or acamprosate should be considered alongside antidepressant therapy to decrease relapse likelihood 3
  • Baclofen may be beneficial in patients with cirrhosis to help maintain abstinence 3

For Insomnia (common in this population):

  • Trazodone (25-100mg at bedtime) has moderate efficacy for improving sleep quality/duration 3, 4
  • Low doses are less problematic than benzodiazepines for sleep 3

Clinical Pearls

  1. Complete abstinence from alcohol should be recommended, as continued alcohol use is associated with disease progression 3

  2. Brief interventions have been shown to reduce drinking by an average of 57g per week in men 3

  3. The combination of SSRIs with alcohol can occasionally lead to unexpected and severe intoxication reactions in some individuals - patients should be warned about this potential interaction 5

  4. Antidepressants primarily address depressive symptoms and may have only modest effects on alcohol consumption itself 6

  5. Consider adding medications that directly target alcohol consumption (naltrexone, acamprosate) to the antidepressant regimen for better outcomes 6

References

Research

[SSRI antidepressants and alcoholism].

Revue medicale de Liege, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Alcohol Use Disorder and Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interaction between antidepressants and alcohol: signal amplification by multiple case reports.

The International journal of risk & safety in medicine, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.